Prognostic factors determining survival in differentiated thyroid cancer

Journal of Surgical Oncology

Volumn 96, Issue 7, 2007, Pages 598-604

  Gulcelik, Mehmet Ali ^a,b   Gulcelik, Nese Ersoz ^a   Kuru, Bekir ^a   Camlibel, Mithat ^a   Alagol, Haluk ^a  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Differentiated thyroid cancer; Extracapsular invasion; Prognostic factors; Vascular invasion

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; TUMOR VOLUME; UNIVARIATE ANALYSIS;

EID: 36549053079     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20845     Document Type: Article

References (34)

1. Gimm O: Thyroid cancer. Cancer Lett 2001;163:143-156.
2. Yildirim E: A model for predicting outcomes in patients with differentiated thyroide cancer and model performance in coparison with other classification systems. J Am Coll Surg 2005;200:378-392.
3. Cooper DS, Doherty GM, Haugen BR, et al.: Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:1-24.
4. Schelfhout LJDM, Creutzberg CL, Hamming JF, et al.: Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age. Eur J Cancer Clin Oncol 1988;24:331-337.
5. Passler C, Scheuba C, Prager G, et al.: Prognostic factors of papillary and follicular thyroid cancer: Differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004;11: 131-139.
6. Jukkola A, Bloigu R, Ebeling T, et al.: Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004;11:571-579.
7. AJCC: Cancer staging manual. 6th edition. New York: Springer-Verlag; 2002.
8. Hay ID, Bergstralh EJ, Goellner JR, et al.: Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058.
9. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-953.
10. Erdogan G, Erdogan MF, Emral R, et al.: Iodine status and goiter prevalence in Turkey before mandatory iodization. J Endocrinol Invest 2002;25:224-228.
11. Gulcelik MA, Gulcelik NE, Dinc S, et al.: The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency. J Surg Oncol 2006;94:35-39.
12. Sosa AJ, Uldesman R: papillary thyroid cancer. Surg Oncol N Am 2006;15:585-601.
13. Krausz Y, Uziely B, Karger H, et al.: Recurrence-associated mortality in patients with differentiated thyroid carcinoma. J Surg Oncol 1993;52:164-168.
14. Ronga G, Filesi M, Montesano T, et al.: Death from differentiated thyroid carcinoma: Retrospective study of a 40-year investigation. Cancer Biother Radiopharm 2002;17:507-514.
15. Schefhout LJDM, Creutzberg CL, Hamming JF, et al.: Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age factor. Eur J Clin Oncol 1988;24:331-337.
16. Bierley JD, Panzeralla T, Tsang RW, et al.: A comparison of different staging systems predictability of patient outcome: Thyroid carcinoma as an example. Cancer 1997;79:2414-2423.
17. DeGroot LJ, Kaplan EL, Straus FH, et al.: Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-130.
18. Passler C, Prager G, Scheuba C, et al.: Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 2003;237:227-234.
19. Cady B, Rossi R: An expanded view of risk-group definition in well differentiated thyroid carcinoma. Surgery 1987;102:1088-1095.
20. Ward LS, Souza SL, Assumpcao LV: The impact of nodal metastases on prognosis of well-differentiated thyroid cancer suggests the practice of prophylactic neck dissection. Arch Otolaryngol Head Neck Surg 2003;129:495-496.
21. Kobayashi T, Asakawa H, Komoike Y, et al.: Characteristics and prognostic factors in patients with differentiated thyroid cancer who underwent a total or subtotal thyroidectomy: Surgical approach for high-risk patients. Surg Today 1999;29:200-203.
22. Sellers M, Beenken S, Blankenship A, et al.: Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992;164:578-581.
23. Simpson WJ, McKinney SE, Carruthers JS, et al.: Papillary and follicular thyroid cancer: Prognostic factors in 1578 patients. Am J Med 1987;83:479-488.
24. Gilliland FD, Hunt WC, Morris DM, et al.: Prognostic factors for thyroid carcinoma. Population-based study of 15 698 cases from surveillance, epidemiology and end results program 1971-1993. Cancer 1997;79:564-573.
25. Segal K, Raveh E, Lubin E, et al.: Well-differentiated thyroid carcinoma. Am J Otolaryngol 1996;17:401-406.
26. DeDroot LJ, Kaplan EL, McCormick M, et al.: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.
27. Loh K, Greenspan FS, Gee L, et al.: Pathological tumor node metastasis (pTNM) staging for papillary and follicular Thyroid carcinomas: Aretrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:3553-3562.
28. Tubiana M, Schlumberger M, Rougier P, et al.: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
29. Ontai S, Straehley CJ: The surgical treatment of well-differentiated carcinoma of the thyroid. Am Surgeon 1985;51:653-657.
30. Eustatia-Rutten CF, Corssmit EP, Biermasz NR, et al.: Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;1:313-319.
31. Falvo L, Catania A, D'Andrea V, et al.: Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg 2005;241:640-646.
32. Lo C-Y, Chan W-F, Lam K-Y, et al.: Follicular thyroid carcinoma: The role of histology and staging systems in predicting survival. Ann Surg 2005;242:708-715.
33. D'Avanzo A, Treseler P, Ituarte PH, et al.: Follicular thyroid carcinoma: Histology and prognosis. Cancer 2004;15:1123-1129.
34. Brennan MD, Bergstrahl EJ, van Heerden JA, et al.: Follicular thyroid cancer treated at Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991;66:11-22.